Analysis of calstabin2 (FKBP12.6)-ryanodine receptor interactions: Rescue of heart failure by calstabin2 in mice

被引:68
作者
Huang, FN [1 ]
Shan, J [1 ]
Reiken, S [1 ]
Wehrens, XHT [1 ]
Marks, AR [1 ]
机构
[1] Columbia Univ, Dept Physiol & Cellular Biophys, Clyde & Helen Wu Ctr Mol Cardiol, New York, NY 10032 USA
关键词
calcium-release channel; immunophilin; isomerase; myocardial infarction; PKA phosphorylation;
D O I
10.1073/pnas.0511282103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The ryanodine receptor (RyR)/calcium-release channel on the sarcoplasmic reticulum mediates intracellular calcium release required for striated muscle contraction. RyR2, the predominant isoform in cardiac myocytes, comprises a macromolecular complex that includes calstabin2 (FKBP12.6). Calstabin2, an 11.8-kDa cis-trans peptidyl-prolyl isomerase (apparent molecular mass 12.6 kDa), stabilizes the closed state of the RyR2 channel, but the mechanism by which it achieves this regulation is not fully understood. Protein kinase A (PKA) phosphorylation of RyR2 decreases the affinity of calstabin2 for the RyR2 channel complex. In the present study we identified key aspartic acid residues on calstabin2 that are involved in binding to RyR2 and likely play a role in PKA phosphorylation-induced dissociation of calstabin2 from RyR2. We show that a mutant calstabin2 in which a key negatively charged residue (Asp-37) has been neutralized binds to a mutant RyR2 channel that mimics constitutively PKA-phosphorylated RyR2 (RyR2-S2808D). Furthermore, using wild-type and genetically altered murine models of heart failure induced by myocardial infarction, we show that manipulating the stoichiometry between calstabin2 and RyR2 can restore normal cardiac function in vivo.
引用
收藏
页码:3456 / 3461
页数:6
相关论文
共 34 条
  • [1] BERS DM, 1994, METHOD CELL BIOL, V40, P3
  • [2] STABILIZATION OF CALCIUM-RELEASE CHANNEL (RYANODINE RECEPTOR) FUNCTION BY FK506-BINDING PROTEIN
    BRILLANTES, AMB
    ONDRIAS, K
    SCOTT, A
    KOBRINSKY, E
    ONDRIASOVA, E
    MOSCHELLA, MC
    JAYARAMAN, T
    LANDERS, M
    EHRLICH, BE
    MARKS, AR
    [J]. CELL, 1994, 77 (04) : 513 - 523
  • [3] BRISTOW MR, 1990, CIRCULATION, V82, P12
  • [4] Structure of FKBP12.6 in complex with rapamycin
    Deivanayagam, CCS
    Carson, M
    Thotakura, A
    Narayana, SVL
    Chodavarapu, RS
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2000, 56 : 266 - 271
  • [5] FK506 BINDING-PROTEIN MUTATIONAL ANALYSIS - DEFINING THE SURFACE RESIDUE CONTRIBUTIONS TO STABILITY OF THE CALCINEURIN CO-COMPLEX
    FUTER, O
    DECENZO, MT
    ALDAPE, RA
    LIVINGSTON, DJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (32) : 18935 - 18940
  • [6] FKBP12 binding modulates ryanodine receptor channel gating
    Gaburjakova, M
    Gaburjakova, J
    Reiken, S
    Huang, F
    Marx, SO
    Rosemblit, N
    Marks, AR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (20) : 16931 - 16935
  • [7] Hogan B., 1986, MANIPULATING MOUSE E
  • [8] ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure)
    Hunt, SA
    Baker, DW
    Chin, MH
    Cinquegrani, MP
    Feldman, AM
    Francis, GS
    Ganiats, TG
    Goldstein, S
    Gregoratos, G
    Jessup, ML
    Noble, RJ
    Packer, M
    Silver, MA
    Stevenson, LW
    Gibbons, RJ
    Antman, EM
    Alpert, JS
    Faxon, DP
    Fuster, V
    Gregoratos, G
    Jacobs, AK
    Hiratzka, LF
    Russell, RO
    Smith, SC
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (07) : 2101 - 2113
  • [9] Crystal structure of the cytoplasmic domain of the type I TGFβ receptor in complex with FKBP12
    Huse, M
    Chen, YG
    Massagué, J
    Kuriyan, J
    [J]. CELL, 1999, 96 (03) : 425 - 436
  • [10] JAYARAMAN T, 1992, J BIOL CHEM, V267, P9474